Editas Medicine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
EDIT Key Statistics
Stock Snapshot
The current Editas Medicine(EDIT) stock price is $2.40, with a market capitalization of 237.7M. The stock trades at a price-to-earnings (P/E) ratio of -0.99.
During the trading session on 2025-12-04, Editas Medicine(EDIT) shares reached a daily high of $2.49 and a low of $2.33. At a current price of $2.40, the stock is +3.0% higher than the low and still -3.6% under the high.
Trading activity shows a volume of 1.57M, compared to an average daily volume of 1.55M.
Over the past 52 weeks, Editas Medicine(EDIT) stock has traded between a high of $4.54 and a low of $0.91.
Over the past 52 weeks, Editas Medicine(EDIT) stock has traded between a high of $4.54 and a low of $0.91.
EDIT News
Image source: The Motley Fool. Wednesday, August 7, 2024 at 12:03 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Gilmore O’Neill Chief Medical Officer — B...
